Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials-Reference-Cited by-同舟云学术

Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials

Published:2016-07 Issue:7 Volume:17 Page:e294-e304
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Ghislain Irina,Zikos Efstathios,Coens Corneel,Quinten Chantal,Balta Vasiliki,Tryfonidis Konstantinos,Piccart Martine,Zardavas Dimitrios,Nagele Eva,Bjelic-Radisic Vesna,Cardoso Fatima,Sprangers Mirjam A G,Velikova Galina,Bottomley Andrew

Publisher

Elsevier BV

Subject

Oncology

Reference75 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Management of locally advanced breast cancer-perspectives and future directions;Tryfonidis;Nat Rev Clin Oncol,2015

3. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2);Cardoso;Breast,2014

4. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2);Cardoso;Ann Oncol,2014

5. Time for more optimism in metastatic breast cancer?;Senkus;Cancer Treat Rev,2014

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Percutaneous microwave ablation: a viable local therapy for breast cancer involving the skin/nipple-areola complex?;Current Problems in Surgery;2024-06

2. Cell Membrane Hybrid Lipid Nanovesicles Enhance Innate Immunity for Synergistic Immunotherapy by Promoting Immunogenic Cell Death and cGAS Activation;Biomaterials Research;2024-01

3. RL2 Enhances the Elimination of Breast Cancer Cells by Doxorubicin;Cells;2023-12-06

4. Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness;Translational Cancer Research;2023-12

5. Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer;JAMA Oncology;2023-10-01